PMID: 26823841Jan 30, 2016Paper

Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer

International Journal of Clinical and Experimental Pathology
Jiaying RuanHe Wang

Abstract

The mixed lineage kinase domain-like protein (MLKL) has recently been identified as a key RIP3 (receptor interacting protein 3) downstream component of tumor necrosis factor (TNF)-induced necroptosis. To evaluate the expression and clinical significance of MLKL in cervical squamous cell carcinoma. The expression of MLKL in 54 cervical squamous carcinoma samples was detected by immuneohistochemical method. Chi-square, correlation analysis and kaplan-Meier method were used to analyze the data. The MLKL expression in cervical squamous cell carcinoma was higher than that in normal cervical tissues (P = 0.004). The MLKL expression was negatively correlated with histological grade, lymphatic metastasis (P<0.05). Survival analysis showed the low expression of MLKL indicated poor prognosis. MLKL was a prognostic biomarker for cervical squamous cell carcinoma.

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.